Bayer Recalls Nearly 800,000 Afrin Bottles Over Child Safety Risk The U.S. Consumer Product Safety Commission (CPSC) announced a recall of nearly 800,000 units of Bayer’s Afrin nasal spray bottles due to a child safety risk. The recall, issued on Thursday, affects 786,100 travel-size 6 mL bottles of the original Afrin nasal spray. The affected products were found to lack child-resistant packaging and proper labeling, posing a significant risk of poisoning if ingested by young children. The CPSC statement detailed that the recall includes unexpired bottles with specific lot numbers: 230361, 240822, 241198, 250066, 250152, 250646, and 250831. These bottles feature the label “Afrin® Original Nasal Spray” and “1/5 FL OZ (6 mL)” on the front. The packaging failure means the bottles do not meet federal safety standards, which require child-resistant designs and clear warnings to prevent accidental access by children. Consumers who purchased the affected products are eligible for refunds. No injuries have been reported in connection with the recall, but the CPSC emphasized the potential danger of the product being accessible to young children. The recall comes amid a broader wave of product safety alerts, including a separate recall of nearly 13,000 toddler tower stools linked to collapse incidents and 21 injuries. The tower stools, produced by three brands—Toetol, Wiifo, and Amzcmj DGD—were recalled for failing to meet safety standards. The CPSC noted that the stools could collapse or tip over, allowing a child’s torso to become trapped, leading to serious injury or death. The recall includes 3,000 Toetol stools, 9,700 Wiifo stools, and 130 Amzcmj DGD stools. Reports of collapses totaled 18, with 11 injuries, including cuts, scrapes, and contusions.#cpsc #bayer #afrin_nasal_spray #child_safety_risk #toetol
